Similarly, in glioblastoma, Suva et al. (2014) identified a core set of neurodevelopmental transcription factors (POU3F2, SOX2, SALL2, and OLIG2) that were sufficient to reprogram differentiated glioblastoma cells to CSCs. This evidence concerns the gene OLIG2 and glioblastoma.